{"name":"RAPT Therapeutics, Inc.","slug":"rapt-therapeutics-inc","ticker":"","exchange":"","domain":"rapt.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9VNDlhLXhmcWU0QmVwekM1YTJjeDBwdHp4VU1RVnNiQXpxWDdEaTMyS3hpOVMtZkQtMDA0QTZfSXhzRkJTbVhhb0J4bDMxTlVacU1jNW51TXFMSVFXdGpKdE9paEFqYkxoQUZoUXlR?oc=5","date":"2026-03-22","type":"pipeline","source":"stocktitan.net","summary":"If You Invested $1,000 in Rapt Therapeutics, Inc. (RAPT) - stocktitan.net","headline":"If You Invested $1,000 in Rapt Therapeutics, Inc. (RAPT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOdnlkamFvRmV3UkEzS2Q2RGVZTHhBOXc4NF9BLWpCYkZoZF9hMDFGb19FNGxfZUVldFVhbFRHLXAzZEJ0cW5fQzRkUi1feFlEMkZyVzkzRWx6UkQ2U3B6YWdjdjRZcTVfZ1l1enVMNW14X1pHWmRHSjlZeTQwSEtwMTBR?oc=5","date":"2026-01-20","type":"deal","source":"Yahoo Finance","summary":"GSK acquires RAPT Therapeutics for $2.2bn - Yahoo Finance","headline":"GSK acquires RAPT Therapeutics for $2.2bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQTktBaW50X1BGbWZ4NFRXbllkNGFiMTFYeDVTWWV5OXhKUmc4cWFtYVp4ZUVCLUZ5bWpiYUxXSDN2eGYwd2JsSGhjYkJ0ZHZXeEZHdkp4c0k4NUJ2NmNaQVB2SkdxRk9Jc1hERTFKZ2lWMWdaS3M0QnNyRDZpTWFISFZidGZyR0VLWXFzTFVmLVpLeWZndWlIdlhldHRYaUFvSUMwVkFsVkNFdkhY?oc=5","date":"2026-01-20","type":"pipeline","source":"Reuters","summary":"GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug - Reuters","headline":"GSK makes $2.2 billion swoop for RAPT Therapeutics' food allergy drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNWXlSaC1oTjhuOXNncjRrT2pwLThucnpVUm9EczdlZ0o1Ynl5LVl4eWtnVTVwam5wZ1RQdDNUQVN4cWtmNDUyZzVmVURGZzdZYWtMdGtzaEtFSTkwVTh5dDlxNExiYl9HZmVCVkkwazFhZTNkX1RyeHl5ay11aC1Cdk8wb09qQVVSbnlGU1Vja2QzaDQ?oc=5","date":"2026-01-20","type":"deal","source":"Seeking Alpha","summary":"GSK to buy RAPT Therapeutics in deal valued at $2.2B (GSK:NYSE) - Seeking Alpha","headline":"GSK to buy RAPT Therapeutics in deal valued at $2.2B (GSK:NYSE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPS2ZKZTR5aHR1eXRIN2hRbW01N0pPVU5haXctN2JGUTNya0c3NUR6M0prSS15SFlYeVc5NHg5UDhsWVlqTHBTdDc3NllHWlZOUVlMeXExTEI5ckV2Y2RmZ0dCRWQzN3N0cE1hRk1rNjdDbFFTcFRqRmdxUEtwakNMUFNORUFqSDluUmxVU01R?oc=5","date":"2026-01-20","type":"deal","source":"Contract Pharma","summary":"GSK Agrees to Acquire RAPT Therapeutics - Contract Pharma","headline":"GSK Agrees to Acquire RAPT Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOVhVV1pOUXhneXVhb3oycTltem9xTGJGX1ZfMnJTajBiZGNiLTNtZUtYZGU2Yy1iODBlY0M3XzNoVmNJZWdwX1o1YjRYajd5X0ZnVURUdTNRczlnbU5SWE9WdFoxWkVNWm4taGZHcFg3Y2VQOEZZRHpWMGdtQ200MVVDTkRYdWQ4ZGpxNkNOUzh2UUJEWnRIeGJkNGNfU3JrS2ZPUkVzTlJKdw?oc=5","date":"2026-01-20","type":"deal","source":"MedCity News","summary":"GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal - MedCity News","headline":"GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMjhzREstV2FGVDI4RmNNTVh6d1BsOU9xaWM4WGRzaVNrdVZiS1U1dmpRX1daTktvaUs0andRM2FEblVBenNmeDBndkRmYjZobmlFbzItT1VYRFlKYldBcVNEM0pXbTJaR0czV3R3Y3ZweHQ1TXAxVm1la0RCTG1QX1RNajVVUVF5UFVidWNCODN4ZGNRSFY5aUd4T3dvY2EzaENySQ?oc=5","date":"2026-01-20","type":"deal","source":"BioPharma Dive","summary":"GSK to buy Rapt in $2.2B deal for food allergy drug - BioPharma Dive","headline":"GSK to buy Rapt in $2.2B deal for food allergy drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPM2xTa3ZjbWpJcGN0ZlFUT29QM2Z2Q0tpb1hLUlRaTFFHT1BYSDJuWGlhcGpGZ3I2aEFUX1R5dllnWWVuOWZVVHE1bFgzMFkzWG0xNWozNUJ3QzRVekltWEQ3c2tvUUFNYmp0aV9qWGhWWmotRTBsS2c1WENMbHRNY1BBdzR3NnhwVXNuc1kwY1ZrZ0NuV3VKUHA0THFoc0xvNGNLaUFqQUF2dnZKT0FLeUJySXA?oc=5","date":"2026-01-20","type":"deal","source":"WSJ","summary":"GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments - WSJ","headline":"GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQdl9RcS13U0Y2X3NVVTBuTWp3MUVUakRkUFd6TzRscTdqaXlPM1g2RjVwbkMtZlRieHRCYnkwaWIwZjdaTFA2azRBLXlyQkFwbGtUT1NQZk5NN1VjQ2FDbTdib0k5STFFNDZoSGt4RW9WRmwyaF9ELUVCUWZzUHlPRkdXaW9pbEhUaExJWEZTbHVMSUhBNEo4dzRVWUNNN1JFR2tuN3N5MHNKVTFzYTBaNjJLblRRLXdxTjBTcXVNTXBNb1dTelM5dEtaU2pxcE96eko4R2VhYl9VOE5yODhNSjRDd1A0bS1TODJISzBEdDF1aGVLbmM1VGR5TWtXTXlSdFViLV9hZUtVR1oyaFNJa3dYUVE0YUtQYzF5SVNYSDktV0N4MW83R3ZyaXFEN2JzQTZyWkZwdmlSNUd5aGJoNGpZbU5hdlE?oc=5","date":"2025-10-20","type":"pipeline","source":"GlobeNewswire","summary":"RAPT Therapeutics and Shanghai Jeyou Pharmaceutical - GlobeNewswire","headline":"RAPT Therapeutics and Shanghai Jeyou Pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQZTJ0bFFhRzZ1a3NvMFMtcW9Rb0pzRzRpVXJ3aDF6Rkh0VjNSSkRGNHJMM0dRaW1QRi1HZDJpaGRHQVA4MXo5UEMzQmhZMWF2SjZWaDRULVZWVklKX25vZ3FlZk0zc2RCN3B5SjRMZVVEV1YtbHVVWUFCU1hRNHBKNHBKRjhSSWk3blow?oc=5","date":"2025-10-19","type":"trial","source":"Yahoo Finance","summary":"RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU) - Yahoo Finance","headline":"RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE8yRGp2aDM2QlFSdjA5eWFVSWVLYnVqR1pVUGwtY28ycTFBT0FiRkxxakVwSlNsd2NaYzFaaUJ3MmFOcV9VYmkxVzBlUllpRmJudmstWUMwWWNsaU03ZC1XVUhWYl9hMHJp?oc=5","date":"2025-09-29","type":"regulatory","source":"MarketBeat","summary":"Rapt Therapeutics (RAPT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"Rapt Therapeutics (RAPT) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdjZEc2hEMEFmeW1SYkg5NTZyWEM5TGVUWjQ4bHI4V2VRc3hRSmVvVGxfdnd5NnpOWTNsMlJlUy05aVFxdjlsc0dBVEQ2M1BpejNIQlBHdFhXeVVGWERoS3ZLb3RxVGkwWFUzWGs2UzVyWXhEeS1HeUlLNGplRm5IVUZDYVZkVmQwdFFSZDMwTlF6QmZDWi1QTEFvUDBWaTB3OUFDcERoVnBYVXktaXc?oc=5","date":"2025-07-15","type":"pipeline","source":"citybiz","summary":"Aegle Therapeutics Names Scott Braunstein, M.D. as Chairman of the Board - citybiz","headline":"Aegle Therapeutics Names Scott Braunstein, M.D. as Chairman of the Board","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}